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Edited by Hans EklundAbstract Lytic transglycosylases cleave the b-(1ﬁ 4)-glyco-
sidic bond in the bacterial cell wall heteropolymer peptidoglycan
between the N-acetylmuramic acid (MurNAc) and N-acetylglu-
cosamine (GlcNAc) residues with the concomitant formation of
a 1,6-anhydromuramoyl residue. Based on sequence alignments,
Ser216 in Pseudomonas aeruginosa membrane-bound lytic trans-
glycosylase B (MltB) was targeted for replacement with alanine
to delineate its role in the enzyme’s mechanism of action. The
speciﬁc activity of the Ser216ﬁ Ala MltB derivative was less
than 12% of that for the wild-type enzyme, while its substrate
binding aﬃnity remained virtually unaltered. These data are in
agreement with a role of Ser216 in orienting the N-acetyl group
on MurNAc at the 1 subsite of MltB for its participation in a
substrate-assisted mechanism of action.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The generally accepted model for the biosynthesis of the bac-
terial cell wall heteropolymer peptidoglycan invokes enzyme
complexes comprised of both lytic transglycosylases (LTs)
and transferases, the latter being a collection of penicillin-bind-
ing proteins (PBPs) [1]. The high-molecular weight PBPs cata-
lyze the incorporation of the newly synthesized and
translocated peptidoglycan precursor molecule, lipid II, into
the existing sacculus at sites made available through the action
of LTs [2,3]. While much eﬀort has been made to understand
the function and mechanism of action of the PBPs, the LTs
have attracted considerably less attention.Abbreviations: GlcNAc, N-acetylglucosamine; HPAEC, high pH
anion-exchange chromatography; LT, lytic transglycosylase; MltB,
membrane-bound lytic transglycosylase B; MurNAc, N-acetylmuramic
acid; PBP, penicillin-binding protein; PED, pulsed electrochemical
detection; sMltB, soluble derivative of membrane-bound lytic trans-
glycosylase B
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doi:10.1016/j.febslet.2007.09.037The LTs are a class of bacterial autolysin that function to
cleave peptidoglycan at the same site as lysozyme (E.C.
3.2.1.17; peptidoglycan N-acetylmuramoyl hydrolase; muram-
idase), speciﬁcally the b-(1ﬁ 4)-glycosidic bond between the
N-acetylmuramic acid (MurNAc) and N-acetylglucosamine
(GlcNAc) residues. However, LTs are catalytically distinct
from the hydrolytic lysozymes (because they cleave peptidogly-
can with the concomitant formation of 1,6-anhydro MurNAc
residues [4]). These enzymes contribute to the metabolism of
peptidoglycan, but their exact role has not been determined
[5,6]. However, it has been demonstrated that the 1,6-anhy-
dromuropeptide products are involved in the pathobiology
of bacterial infections [7–9].
LTs appear to be ubiquitous in the eubacteria that produce
peptidoglycan (viz. all but the cell wall-less mycoplasmas) [10].
Our laboratory has been engaged in the biochemical character-
ization of LTs from Gram-negative organisms, and in particu-
lar Pseudomonas aeruginosa. We have provided a kinetic
characterization of the family 3 membrane-bound lytic trans-
glycosylase B (MltB) [11] and the ﬁrst report of substrate aﬃn-
ity for this class of enzyme [12]. Work with the b-
hexosaminidase inhibitor NAG-thiazoline [13] has suggested
that the LT mechanism employs substrate-assisted catalysis
[14,15], while a genetic engineering study demonstrated the
importance of both Arg187 and Arg188 with substrate recog-
nition and binding at subsite 1 of the active site cleft [16].
This latter study also suggested the potential importance of
the stem peptide of substrate in catalysis, possibly involving
the highly conserved Ser216 residue.
Here, we further our characterization of an engineered, sol-
uble derivative of P. aeruginosa MltB (sMltB) by investigating
the role in catalysis of Ser216 in the 1 subsite of its active site
cleft. Site directed mutagenesis was employed to replace Ser216
with Ala and the generated enzyme derivative was character-
ized kinetically.2. Materials and methods
2.1. Chemical reagents and enzymes
Complete EDTA-free protease inhibitor tablets, glycine, and isopro-
pyl-(b)-D-thiogalactoside (IPTG) were purchased from Roche Molecu-
lar Biochemicals (Laval, PQ). Ni-NTA resin was obtained from Qiagen
(Valencia, CA) while the Source 15S column was supplied by Pharma-
cia Biotech (Baie d’Urfe´, PQ). All other chemicals were purchased
from either Sigma Chemical Co. (St. Louis, MO) or Fisher Scientiﬁc
(Nepean, ON), and were of reagent grade or HPLC-grade where
appropriate.
Peptidoglycan was isolated and puriﬁed from P. aeruginosa PA01 as
previously described [17]. The isolated peptidoglycan was treated withblished by Elsevier B.V. All rights reserved.
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scribed by Glauner [18].2.2. Bacterial strains and growth conditions
Bacterial strains used in this study were Escherichia coli DH5 (Gib-
co/BRL, Burlington, ON) for cloning and E. coli BL21(DE3) (Nova-
gen, Madison, WI) for protein expression. Cultures were routinely
grown in Luria–Bertani (LB; 1% tryptone peptone, 1% NaCl, and
0.5% yeast extract) broth or LB-agar plates at 37 C. For protein
expression experiments, cells were grown in Super Broth (3.2%
tryptone peptone, 0.5% NaCl, and 2% yeast extract) at either 15 C
or 37 C, as appropriate [11]. When necessary, growth media
were supplemented with antibiotics at the following concentra-
tions: kanamycin (Km; 30 lg mL1) or chloramphenicol (Cam;
34 lg mL1).2.3. Site-directed mutagenesis
The Quick-Change (site-directed mutagenesis) system (Stratagene,
LaJolla, CA) was used to engineer the smltB gene encoding the single
Ser216ﬁ Ala replacement within sMltB. Conditions for the mutagen-
esis PCR were those described by the manufacturer using PfuTurbo
DNA polymerase. Plasmid pNBAC54-1 [11] was used as template in
the PCR using the following primers: 5 0-CGCTGGCCCtgcGCG-
GTGCCTATGCCGGC-30 and 5 0-CGTAGCCCATGGCGCCGgca-
TAGGCACCGC-3 0, with the bases in lower case and underlined rep-
resenting those changed to introduce the desired mutation.2.4. Isolation and puriﬁcation of sMltB
The production and puriﬁcation to apparent homogeneity of both
the wild-type P. aeruginosa sMltB and its Ser216ﬁ Ala mutant deriv-
ative from appropriate E. coli transformants were conducted as previ-
ously described [11].2.5. Assay for LT activity
The speciﬁc activity of puriﬁed sMltB and its Ser216ﬁ Ala deriva-
tive was measured using the assay developed by Blackburn and Clarke
[19]. Brieﬂy, sMltB was incubated at 37 C in the presence of puriﬁed
peptidoglycan suspended in 50 mM sodium acetate buﬀer, pH 5.8 con-
taining 0.1% Triton X-100. At appropriate time intervals, samples were
ﬂash frozen at 78 C to halt the reaction. The insoluble peptidogly-
can was removed from the thawed samples by centrifugation
(18,000 · g, 20 min, 4 C), and the recovered supernatants containing
the released and soluble muropeptides were evaporated to dryness.
The dried samples were hydrolyzed with 5.8 M HCl for 2 h at 98 C
and evaporated to dryness. The glucosamine content of the hydrolyzed
samples was measured by high pH anion-exchange chromatography
(HPAEC) using a PA1 pellicular anion-exchange column
(4 · 250 mm) with pulsed electrochemical detection (PED) (Dionex,
Oakville, ON) [17]. For the analysis of muropeptide proﬁles of enzyme
digests, insoluble peptidoglycan was removed from reaction mixtures
by centrifugation (18,000 · g, 20 min, 4 C) and the supernatants were
analyzed by HPAEC as previously described [11]. The data are pre-
sented as the average of at least three trials (±S.D.) using diﬀerent
preparations of enzymes.2.6. Zymography
Zymograms involving the suspension of puriﬁed peptidoglycan in
12.5% polyacrylamide gels to a ﬁnal concentration of 0.1% were per-
formed as previously described [20–22].2.7. Peptidoglycan binding assay
The binding of wild-type sMltB and the Ser216ﬁ Ala derivative to
insoluble P. aeruginosa peptidoglycan was analyzed using a procedure
described by Ursinus et al. [16,23] with modiﬁcations. Following incu-
bation, insoluble peptidoglycan was recovered by centrifugation
(18,000 · g, 20 min, 4 C), and the retained supernatants were analyzed
by SDS–PAGE with Western immunoblot detection using an anti-His
monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Relative intensities of the protein bands were determined with a GS-
800 densitometer using the Quantity-One software package (Bio-Rad
Laboratories).2.8. Diﬀerence UV absorbance spectroscopy
Diﬀerence absorbance spectra of puriﬁed sMltB and its Ser216-Ala
derivative were obtained as previously described [12]. Brieﬂy, UV
absorbance scans (220–320 nm) of enzyme samples (6 lM) in 10 mM
ammonium acetate buﬀer, pH 6.5 containing 100 mM NaCl were col-
lected using a Beckman DU-530 spectrophotometer after the sequen-
tial addition of ligand and incubation for 90 s at room temperature.
Each scan was corrected for dilution by multiplying with a correction
factor [ðP V t þ V iÞ=V i, where Vt is the titration volume and Vi is the
initial volume]. Scans were normalized by subtraction of the scan at
zero ligand concentration and the trough to peak height at A287 nm–
A281 nm and A253 nm–A276 nm were plotted versus the total ligand con-
centration, and dissociation constants (Kd) were derived using a non-
linear regression analysis with a two-site binding model (Microcal Ori-
gin 5.0).2.9. Other analytical methods
SDS–PAGE was performed as described by Laemmli [24] and gels
were stained with Coomassie Brilliant Blue R-250 as described by Bol-
lag et al. [25]. Protein concentrations were measured using the BCA
protein assay kit supplied by Sigma with BSA serving as the standard.3. Results and discussion
3.1. Production and activity of Ser216ﬁ Ala sMltB
Based on previous protein engineering and inhibition studies
with NAG-thiazoline, we demonstrated that the mechanism of
action of the family 3 LT MltB from P. aeruginosa invokes
substrate-assisted catalysis which proceeds through an oxazo-
linium intermediate involving the N-acetyl group on MurNAc
[15]. For this to occur, the N-acetyl group would have to be
appropriately oriented at subsite 1 of the active site cleft.
Examination of the three-dimensional structure of E. coli
Slt35 and an alignment of the amino acid sequences of the fam-
ily 3 LTs (data not shown) permitted the identiﬁcation of
Ser216 in P. aeruginosaMltB as a potential candidate to favor-
ably position the N-acetyl moiety for intramolecular participa-
tion. This residue was thus targeted for site-speciﬁc
replacement with alanine and the eﬀects on enzyme activity
and substrate binding were investigated.
The genes encoding wild-type sMltB and its Ser216ﬁ Ala
derivative were expressed in respective E. coli transformants,
as conﬁrmed by SDS–PAGE and Western blot analysis using
an anti-His tag monoclonal antibody (data not shown). Both
enzymes were puriﬁed to apparent homogeneity by a combina-
tion of aﬃnity chromatography on Ni2+-NTA agarose and
cation-exchange chromatography on Mono S (data not
shown). Care was taken to use new Ni2+-NTA agarose and a
thoroughly washed Mono S column for these puriﬁcations to
preclude the possible contamination of the two proteins with
each other.
Zymogram analysis of Ser216ﬁ Ala sMltB using insoluble
P. aeruginosa peptidoglycan as substrate indicated that its
cleavage activity was signiﬁcantly reduced compared to the
wild-type enzyme at the same protein concentration (Fig. 1).
Using the HPAEC-based assay developed previously for LTs
[11], the soluble muropeptides released from insoluble PG by
the mutant form of sMltB were identiﬁed and found to be
the same as those generated by the wild-type enzyme
(Fig. 1). The amount of released muropeptides was quantiﬁed
over a 30 min period [19], and the speciﬁc activity of
Ser216ﬁ Ala sMltB was found to be 89% lower than that of
the wild-type (1.45 ± 0.56 nmol min1 mg1 compared to
13.0 ± 4.1 nmol min1 mg1). Unfortunately, this low level of
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Fig. 2. Aﬃnity assay of wild-type and Ser216ﬁ Ala sMltB for
insoluble peptidoglycan. Binding reactions were performed with
approx. 10 lg protein and 100 lg P. aeruginosa PAO1 peptidoglycan
(‘‘+’’ lanes). To account for the non-speciﬁc adsorption of protein to
the microfuge tubes, control experiments were performed that lacked
added PG (‘‘’’ lanes). After incubation for 15 min on ice, PG was
isolated (Sample), washed (Wash), and then extracted (Elution) with
2% SDS. Following each step, the PG was recovered by centrifugation
and supernatants were subjected to SDS–PAGE and Western immu-
noblot analysis using the a-His probe.
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Fig. 1. Lytic activity of sMltB and its Ser216ﬁ Ala derivative.
Depicted is a representative HPEAC proﬁle of muropeptides generated
by reaction of wild-type sMltB with P. aeruginosa PG at 37 C for
15 min. HPLC conditions were as described in Section 2. The
muropeptides identiﬁed were: (a) anhydro-disaccharide-tetrapeptide,
(b) anhydro-disaccharide-tripeptide, and (c) cross-linked anhydro-
disaccharide-tetrasaccharide. Inset: Zymogram of sMltB and mutant
derivative using 0.1% (w/v) P. aeruginosa peptidoglycan as substrate.
Both lanes were loaded with an equal amount of protein as determined
by BCA protein assay.
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plexity of the assay and its associated large margins of error,
precluded our ability to determine its Michaelis–Menten
parameters with suﬃcient accuracy.
3.2. Substrate-binding capacity of Ser216ﬁ Ala sMltB
To delineate the cause for the loss in catalytic activity, the
wild-type and Ser216ﬁ Ala sMltB were analyzed for their
ability to bind insoluble peptidoglycan using an adsorption as-
say. Both enzymes (10 lg protein) were incubated on ice in the
presence of 100 lg insoluble peptidoglycan. The insoluble
material, including any bound protein, was removed by centri-
fugation and the pellet was washed free of any non-speciﬁcally
bound proteins. Bound protein was extracted from the pepti-
doglycan by incubation in 2% SDS and all fractions were ana-
lyzed by SDS–PAGE. Using an anti-His tag monoclonal
antibody in Western immunoblot assays, the percentage of
bound protein was calculated based on the amount of proteinTable 1
Aﬃnity of sMltB and Ser216ﬁ Ala derivative for peptidoglycan and comp
Enzyme Peptidoglycan-binding assaya
% Boundc % Recoveredd
WT 93 ± 10 64 ± 16
S216A 90 ± 14 79 ± 10
aThe binding assay was conducted as described in the legend to Fig. 2 (±S.D
bDiﬀerence UV absorbance scans were obtained of the enzymes in 10 mM am
either GlcNAc–MurNAc–dipeptide (GlcNAc–MurNAc–diP) or MurNAc–d
cCalculated by diﬀerence based on the amount of protein remaining in the sup
protein applied.
dBased on the amount of protein recovered in SDS extracts of peptidoglycaremaining in the supernatant of the sample (containing pepti-
doglycan) and the control (no peptidoglycan). As can be seen
in Fig. 2 and Table 1, the Ser216ﬁ Ala mutant does not have
an altered binding dissociation constant for insoluble peptido-
glycan as compared to the wild-type enzyme.
Diﬀerence UV absorbance spectroscopy was also used to as-
sess the ligand binding properties of Ser216ﬁ Ala sMltB. As
with the wild-type enzyme [12], the diﬀerence spectra of
Ser216ﬁ Ala sMltB showed a negative trough at 277 nm with
a red shift upon titration with either GlcNAc–MurNAc–dipep-
tide or MurNAc–dipeptide (data not shown). The red shifts
indicated a conformational change of an aromatic residue(s)
to a more non-polar environment. Saturation curves of
Ser216ﬁ Ala sMltB titrated with these two ligands and trans-
formation of the data provided Kd values which were very sim-
ilar to those obtained with the wild-type enzyme (Table 1).
Taken together, these data suggest that replacement of
Ser216 with Ala does not aﬀect the binding of substrate and
that the reduced speciﬁc activity observed with the mutant en-
zyme is thus likely caused by an eﬀect on its catalytic mecha-
nism. This would be expected if Ser216 was indeed involved
in orienting the N-acetyl group on MurNAc at the 1 subsite
for its subsequent attack on the anomeric center of the transi-
tion state to generate the putative oxazolinium intermediate.4. Concluding remarks
With only one catalytic acid appropriately positioned at
their active center, LTs are believed to catalyze the cleavageonents
Kd (lM) by UV diﬀerence spectroscopy
b
MurNAc–diP GlcNAc–MurNAc–diP
52.3 ± 12 22.6 ± 0.31
70.3 ± 7.9 44.0 ± 0.84
., n = 3).
monium acetate buﬀer, pH 6.5 containing 100 mM NaCl titrated with
ipeptide (MurNAc–diP) at 25 C.
ernatant after incubation with insoluble peptidoglycan relative to total
n pellets relative to total protein originally applied.
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mechanism which proceeds through an oxazolinium substrate
intermediate (Fig. 3). In the LT Slt70 and a number of family
GH-18 chitinases, two amino acid residues have been identiﬁed
that coordinate the N-acetyl group of substrate in the 1 sub-
site and increase the nucleophilicity of its N-acetyl carbonyl
[26–28]. With E. coli Slt70, Ser487 and Glu583, respectively,
are thought to serve these functions. Evidence obtained in
the current study suggests that Ser216 is involved in properly
orienting the N-acetyl group on MurNAc for formation of
the oxazolinium intermediate in P. aeruginosa sMltB. Family
3 LTs, however, appear to lack a homolog of the acidic residue
at the 1 subsite. To accommodate for this apparent deﬁ-
ciency, van Asselt et al. [29] have proposed that the D-Glu res-
idue of the stem peptide at the +2 subsite provides a functional
substitution for the acidic residue on the enzyme. Indeed, they
found that this free stem peptide in the +2 subsite could be
modeled such that the free carboxyl of its D-Glu was in posi-
tion to interact with the MurNAc N-acetyl group in the 1
subsite and thereby activate it for nucleophilic attack. This
hypothesis is supported by our previous demonstration that
the stem peptides on peptidoglycan substrates are important
for binding to sMltB [16]. The observation that the MltBs fromboth E. coli [30] and P. aeruginosa [11] have an absolute
requirement for the stem peptide portion of peptidoglycan
for activity further substantiates this postulate. However, a de-
tailed investigation will be required to conﬁrm the role of this
neighboring stem peptide on the peptidoglycan substrate in,
what would be, a substrate-assisted–substrate-assisted mecha-
nism of action.
Whereas we have argued that Ser216 participates in the
mechanism of action of sMltB by helping to coordinate sub-
strate at subsite 1, there are other possible explanations for
the eﬀect of its replacement on catalysis. For example, the
replacement of Ser216 with Ala may have provoked a subtle
conformational change in the active site to aﬀect the local envi-
ronment of Glu162 thereby lowering its eﬀectiveness as the cat-
alytic acid/base. Alternatively, Ser216 may indeed serve to
properly orient the stem peptide of ligand at subsite 1 which
in turn assists in the catalytic mechanism. At present, these
possibilities cannot be excluded and structural studies would
be required to conﬁrm our hypothesis.Acknowledgement: These studies were supported by an operating
Grant (MOP 49623) to A.J.C. from the Canadian Institutes of Health
Research.
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